ARCB Stock Analysis: ArcBest | NASDAQ
Trucking | NASDAQ, USA | Market Cap: 2.905m USD | 12M Return: 74.4% | US03937C1053 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 23.9M
EPS Trend: -92.8%
Qual. Beats: 0
Rev. Trend: -85.5%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
ArcBest Corporation (NASDAQ: ARCB) is a U.S.-based integrated logistics company headquartered in Fort Smith, Arkansas, founded in 1923 and formerly known as Arkansas Best Corporation until its 2014 rebranding. The company is classified within the Industrials sector, specifically the Cargo Ground Transportation sub-industry, and operates as a mid-cap stock with operations spanning ground, air, and ocean transportation worldwide.
ArcBest runs two complementary segments. The Asset-Based segment focuses on less-than-truckload (LTL) services, transporting general commodities such as food, textiles, chemicals, and automotive parts, and also provides motor carrier freight services into Mexico through partner trucking companies. LTL freight is a model in which multiple shippers goods share space on a single truck, distinguishing it from full-truckload carriers that haul dedicated loads.
The Asset-Light segment delivers a broad portfolio of third-party logistics (3PL) services, including ground expedite, transportation brokerage (covering dry van, refrigerated, flatbed, intermodal, and specialized equipment), ocean freight (both less-than-container and full container), warehousing and distribution, managed transportation, and consumer moving services. It also offers premium logistics with specialized equipment deployment and international air, ocean, and ground freight forwarding.
- LTL tonnage and pricing trends drive Asset-Based margins
- Asset-Light brokerage revenue growth outpaces legacy LTL segment
- Truckload rate softness pressures brokerage operating margins
| Net Income: 16.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 5.19 > 1.0 |
| NWC/Revenue: -0.55% < 20% (prev -0.57%; Δ 0.02% < -1%) |
| CFO/TA 0.11 > 3% & CFO 281.1m > Net Income 16.3m |
| Net Debt (535.5m) to EBITDA (210.8m): 2.54 < 3 |
| Current Ratio: 0.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (22.3m) vs 12m ago -3.47% < -2% |
| Gross Margin: 53.78% > 18% (prev 7.76%; Δ 46.03% > 0.5%) |
| Asset Turnover: 170.9% > 50% (prev 164.3%; Δ 6.61% > 0%) |
| Interest Coverage Ratio: 2.13 > 6 (EBIT TTM 32.4m / Interest Expense TTM 15.2m) |
| A: -0.01 (Total Current Assets 706.5m - Total Current Liabilities 729.6m) / Total Assets 2.45b |
| B: 0.60 (Retained Earnings 1.46b / Total Assets 2.45b) |
| C: 0.01 (EBIT TTM 32.4m / Avg Total Assets 2.46b) |
| D: 1.07 (Book Value of Equity 1.27b / Total Liabilities 1.18b) |
| Altman-Z'' = 3.10 = A |
| DSRI: 0.99 (Receivables 463.0m/449.0m, Revenue 4.20b/4.05b) |
| GMI: 0.14 (GM 7.76% / 53.78%) |
| AQI: 0.91 (AQ_t 0.18 / AQ_t-1 0.20) |
| SGI: 1.04 (Revenue 4.20b / 4.05b) |
| TATA: -0.11 (NI 16.3m - CFO 281.1m) / TA 2.45b) |
| Beneish M = -3.85 (Cap -4..+1) = AAA |
As of October 24, 2026, the stock is trading at USD 127.01 with a total of 255,882 shares traded. Over the past week, the price has changed by -2.28%, over one month by -3.10%, over three months by -19.02% and over the past year by +74.35%.
Current recommended Stop Loss: 121.90 (which is 4% or 1.2 ATR below the current price).
ArcBest has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy ARCB.
- StrongBuy: 6
- Buy: 2
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 166.9 | 31.4% |
P/E Trailing = 188.3913
P/E Forward = 13.7174
P/S = 0.6911
P/B = 2.2738
P/EG = 0.4985
Revenue TTM = 4.20b USD
EBIT TTM = 32.4m USD
EBITDA TTM = 210.8m USD
Long Term Debt = 121.1m USD (from longTermDebt, last quarter)
Short Term Debt = 130.7m USD (from shortTermDebt, last quarter)
Debt = 704.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 244.2m
Net Debt = 535.5m USD (calculated: Debt 704.0m - CCE 168.4m)
Enterprise Value = 3.44b USD (2.91b + Debt 704.0m - CCE 168.4m)
Interest Coverage Ratio = 2.13 (Ebit TTM 32.4m / Interest Expense TTM 15.2m)
EV/FCF = 17.89x (Enterprise Value 3.44b / FCF TTM 192.4m)
FCF Yield = 5.59% (FCF TTM 192.4m / Enterprise Value 3.44b)
FCF Margin = 4.58% (FCF TTM 192.4m / Revenue TTM 4.20b)
Net Margin = 0.39% (Net Income TTM 16.3m / Revenue TTM 4.20b)
Gross Margin = 53.78% ((Revenue TTM 4.20b - Cost of Revenue TTM 1.94b) / Revenue TTM)
Gross Margin QoQ = none% (prev 0.34%)
Tobins Q-Ratio = 1.40 (Enterprise Value 3.44b / Total Assets 2.45b)
Interest Expense / Debt = 2.16% (Interest Expense 15.2m / Debt 704.0m)
Taxrate = 21.13% (4.37m / 20.7m)
NOPAT = 25.6m (EBIT 32.4m * (1 - 21.13%))
Current Ratio = 0.97 (Total Current Assets 706.5m / Total Current Liabilities 729.6m)
Debt / Equity = 0.56 (Debt 704.0m / totalStockholderEquity, last quarter 1.27b)
Debt / EBITDA = 2.54 (Net Debt 535.5m / EBITDA 210.8m)
Debt / FCF = 2.78 (Net Debt 535.5m / FCF TTM 192.4m)
Total Stockholder Equity = 1.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.66% (Net Income 16.3m / Total Assets 2.45b)
RoE = 1.26% (Net Income TTM 16.3m / Total Stockholder Equity 1.29b)
RoCE = 2.29% (EBIT 32.4m / Capital Employed (Equity 1.29b + L.T.Debt 121.1m))
RoIC = 1.52% (NOPAT 25.6m / Invested Capital 1.69b)
WACC = 7.13% (E(2.91b)/V(3.61b) * Re(8.45%) + D(704.0m)/V(3.61b) * Rd(2.16%) * (1-Tc(0.21)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.83 | Cagr: -2.33%
[DCF] Terminal Value 77.97% ; FCFF base≈141.7m ; Y1≈162.4m ; Y5≈239.0m
[DCF] Fair Price = 136.9 (EV 3.60b - Net Debt 535.5m = Equity 3.06b / Shares 22.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -92.75 | EPS CAGR: -27.25% | SUE: 0.54 | # QB: 0
Revenue Correlation: -85.49 | Revenue CAGR: -3.93% | SUE: 0.92 | # QB: 1
EPS current Quarter (2026-09-30): EPS=2.51 | Chg30d=+4.39% | Revisions=+80% | Analysts=13
EPS current Year (2026-12-31): EPS=7.04 | Chg30d=+2.09% | Revisions=+53% | GrowthEPS=+90.3% | GrowthRev=+12.4%
EPS next Year (2027-12-31): EPS=9.56 | Chg30d=+0.16% | Revisions=+46% | GrowthEPS=+35.8% | GrowthRev=+7.9%
[Analyst] Revisions Ratio: +70% (up=30, down=4)